Tag archive for ‘SUSTAIN and SURPASS trials of brincidofovir’
Chimerix: Upgrading the Stock to a Buy (CMRX. Buy, $6.10)
Definitions of Key Words This section defines a number of words, phrases and acronyms that I have used in this report that may be useful for investors who may not have already done extensive research on Chimerix. virus: A virus is a small, non- bacterial, infectious agent that replicates only inside the living cells of […]